- Home
- MYGN vs OFG Comparison
MYGN vs OFG Comparison
Compare MYGN & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYGN | OFG |
|---|---|---|
| Founded | 1991 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.5M | 2.0B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | MYGN | OFG |
|---|---|---|
| Price | $6.16 | $41.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $11.82 | ★ $45.75 |
| AVG Volume (30 Days) | ★ 921.9K | 249.2K |
| Earning Date | 11-03-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | N/A | ★ 6.55 |
| EPS | N/A | ★ 4.40 |
| Revenue | ★ $825,300,000.00 | $624,004,000.00 |
| Revenue This Year | $0.08 | N/A |
| Revenue Next Year | $5.28 | $1.02 |
| P/E Ratio | ★ N/A | $9.44 |
| Revenue Growth | ★ 0.21 | N/A |
| 52 Week Low | $3.76 | $33.15 |
| 52 Week High | $15.47 | $46.11 |
Technical Indicators
Market Signals| Indicator | MYGN | OFG |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 48.80 |
| Support Level | $6.38 | $41.75 |
| Resistance Level | $6.89 | $42.44 |
| Average True Range (ATR) | 0.28 | 0.73 |
| MACD | -0.08 | -0.09 |
| Stochastic Oscillator | 0.00 | 19.87 |
Price Performance
Historical ComparisonAbout MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.